14,905 Shares in Zoetis Inc. (NYSE:ZTS) Bought by L & S Advisors Inc

L & S Advisors Inc purchased a new stake in Zoetis Inc. (NYSE:ZTS) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 14,905 shares of the company’s stock, valued at approximately $2,584,000.

Several other institutional investors have also added to or reduced their stakes in ZTS. Vanguard Group Inc. grew its position in Zoetis by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 40,749,571 shares of the company’s stock worth $6,895,235,000 after purchasing an additional 414,605 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Zoetis by 31.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after buying an additional 3,244,074 shares during the last quarter. Capital World Investors grew its holdings in shares of Zoetis by 0.6% during the fourth quarter. Capital World Investors now owns 9,064,158 shares of the company’s stock valued at $1,788,988,000 after buying an additional 57,798 shares during the last quarter. Bank of New York Mellon Corp raised its stake in Zoetis by 4.0% in the 2nd quarter. Bank of New York Mellon Corp now owns 4,687,902 shares of the company’s stock worth $812,695,000 after acquiring an additional 178,303 shares during the last quarter. Finally, Capital Research Global Investors raised its stake in Zoetis by 2.3% in the 1st quarter. Capital Research Global Investors now owns 4,050,681 shares of the company’s stock worth $685,416,000 after acquiring an additional 90,330 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ZTS. Argus raised Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Piper Sandler raised their price target on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 14th. BTIG Research lifted their price objective on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $200.00 price objective on shares of Zoetis in a research note on Tuesday, August 27th. Nine research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $217.11.

Zoetis Stock Up 1.7 %

ZTS stock opened at $194.25 on Tuesday. The firm’s fifty day moving average is $183.22 and its 200 day moving average is $174.12. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. Zoetis Inc. has a one year low of $144.80 and a one year high of $201.92. The firm has a market cap of $88.00 billion, a PE ratio of 37.43, a P/E/G ratio of 2.92 and a beta of 0.88.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The company had revenue of $2.36 billion during the quarter, compared to analysts’ expectations of $2.31 billion. During the same quarter in the prior year, the firm posted $1.41 EPS. Zoetis’s quarterly revenue was up 8.3% compared to the same quarter last year. On average, research analysts forecast that Zoetis Inc. will post 5.84 EPS for the current year.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.